Bausch Health Companies (BHC) Reports Q2 Revenues of $2.125B; Boosts FY18 Adj. EBITDA Guidance, Offers FY18 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bausch Health Companies (BHC) PT Raised to $26 at RBC Capital
August 8, 2018 8:12 AM EDTRBC Capital raised its price target on Bausch Health Companies (NYSE: BHC) to $26.00 (from $25.00) while maintaining a Sector Perform rating.
... MoreBausch Health Companies (BHC) PT Raised to $30 at Deutsche Bank
August 8, 2018 6:32 AM EDTDeutsche Bank raised its price target on Bausch Health Companies (NYSE: BHC) to $30.00 (from $25.00) while maintaining a Buy rating.
Analsyt Gregg Gilbert commented, "BHC reported solid 2Q18 results, with revenue, EBITDA, and EPS coming in above our model (cash flow from ops... More
Bausch Health Co. Inc. (BHC) Subsidiaries, US WorldMeds LLC & Salix Pharma, Report U.S. Launch of LUCEMYRA (lofexidine) 0.18 Mg Tablets
August 6, 2018 7:11 AM EDTUS WorldMeds, LLC, and Salix Pharmaceuticals, a wholly owned subsidiary of Bausch Health Companies Inc. (NYSE: BHC), today announced the U.S. launch and availability of LUCEMYRA (lofexidine) 0.18 mg tablets, the first and only non-opioid medication indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.
The Centers for Disease Control and Prevention estimates that more than 115 people in the U.S. die each day from opioid overdose.1 Often overlooked, opioid withdrawal is one of the most powerful barriers keeping people from discontinuing opioids. Many people have such difficulty... More
